Search Results - Wirth, Lori J., MD

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Vemurafenib in patients with BRAFV600E -positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial

    Vemurafenib in patients with BRAFV600E -positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, ph... by Brose, Marcia S, Dr, Cabanillas, Maria E, MD, Cohen, Ezra E W, Prof, Wirth, Lori J, MD, Riehl, Todd, PharmD, Yue, Huibin, PhD, Sherman, Steven I, Prof, Sherman, Eric J, MD

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    DNA Damage Response Assessments in Human Tumor Samples Provide Functional Biomarkers of Radiosensitivity

    DNA Damage Response Assessments in Human Tumor Samples Provide Functional Biomarkers of Radiosensitivity by Willers, Henning, MD, Gheorghiu, Liliana, MS, Liu, Qi, PhD, Efstathiou, Jason A., MD, DPhil, Wirth, Lori J., MD, Krause, Mechthild, MD, von Neubeck, Cläre, PhD

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: